There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Perrigo Company plc (NYSE: PRGO) and Teva Pharma (NYSE: TEVA) with bullish sentiments.
Perrigo Company plc (NYSE: PRGO)
Canaccord Genuity analyst Dewey Steadman maintained a Buy rating on Perrigo Company plc (NYSE: PRGO) today and set a price target of $105. The company’s shares opened today at $74.94.
According to TipRanks.com, Steadman has 0 stars on 0-5 star ranking scale with an average return of -4.7% and a 40.7% success rate. Steadman covers the Healthcare sector, focusing on stocks such as ANI Pharmaceuticals Inc, Pacira Pharmaceuticals, and Cardiome Pharma Corp.
Currently, the analyst consensus on Perrigo Company plc is Moderate Buy and the average price target is $96.60, representing a 28.9% upside.
In a report issued on May 11, Cantor Fitzgerald also assigned a Buy rating to the stock with a $107 price target.
See today’s analyst top recommended stocks >>
Teva Pharma (NYSE: TEVA)
Credit Suisse analyst Vamil Divan maintained a Buy rating on Teva Pharma (NYSE: TEVA) today and set a price target of $23. The company’s shares opened today at $20.38.
According to TipRanks.com, Divan ‘s ranking currently consits of no stars on a 0-5 ranking scale, with an average return of -2.9% and a 42.8% success rate. Divan covers the Healthcare sector, focusing on stocks such as Aimmune Therapeutics, Johnson & Johnson, and Eli Lilly & Co.
Currently, the analyst consensus on Teva Pharma is Hold and the average price target is $19.92, representing a -2.3% downside.
In a report issued on May 7, Mizuho Securities also reiterated a Buy rating on the stock with a $27 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on TEVA:
